Elicio Therapeutics(ELTX)
$1.48-0.02 (-1.33%)
ELTX
Elicio Therapeutics earnings date
$1.48
At close:-0.02 (-1.33%)
Want to see ELTX full AI Analyst Report?
Elicio Therapeutics (ELTX) Q2 2026 Earnings Report
279 Followers
ELTX Q2 2026 EPS Results
- Actual EPS
- -$0.43
- Consensus EPS
- -$0.54
- Beat/Miss
- Beat by +$0.11
- One Year Ago EPS
- -$0.66
ELTX Q2 2026 Revenue Results
- Actual Revenue
- $0
- Expected Revenue
- $0
- Beat/Miss
- Met expectations
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q2 2026
- Date
- 08/13/2026
- Time
- After Close
- Conference Call
- Thursday, August 13, 2026
ELTX Upcoming Earnings
Elicio Therapeutics's next earnings date is estimated for March 26, 2027, based on past reporting schedules.
Q2 2026 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2026 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2026 Earnings Call Summary
No earnings call summary is available for this earnings event.
ELTX Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 26, 2027 | 2026 (Q4) | -0.31- | -0.45 | ― | ― |
| Nov 05, 2026 | 2026 (Q3) | -0.48-0.30 | -0.6 | 50.00% (+0.30) | |
| Aug 13, 2026 | 2026 (Q2) | -0.54-0.43 | -0.66 | 34.85% (+0.23) | |
| May 11, 2026 | 2026 (Q1) | -0.47-0.65 | -0.87 | 25.29% (+0.22) | |
| Mar 12, 2026 | 2025 (Q4) | -0.45-0.45 | -1.07 | 57.94% (+0.62) | |
| Nov 13, 2025 | 2025 (Q3) | -0.48-0.60 | -1.39 | 56.83% (+0.79) | |
| Aug 07, 2025 | 2025 (Q2) | -0.69-0.66 | -0.64 | -3.13% (-0.02) | |
| May 13, 2025 | 2025 (Q1) | ―-0.87 | -1.15 | 24.35% (+0.28) | |
| Mar 31, 2025 | 2024 (Q4) | -0.83-0.87 | -1.15 | 24.35% (+0.28) | |
| Nov 13, 2024 | 2024 (Q3) | -0.73-1.39 | -1.27 | -9.45% (-0.12) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed

